1. Home
  2. APGE

as 09-05-2025 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Founded: 2022 Country:
United States
United States
Employees: N/A City: WALTHAM
Market Cap: 2.0B IPO Year: 2023
Target Price: $95.40 AVG Volume (30 days): 431.7K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -4.12 EPS Growth: N/A
52 Week Low/High: $26.20 - $63.50 Next Earning Date: 08-11-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

APGE Daily Stock ML Predictions

Share on Social Networks: